Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 6/2012

01.11.2012 | Clinical Investigation

Novel automated screening of age-related macular degeneration

verfasst von: Yasuyuki Yamauchi, Hiroyuki Kemma, Hiroshi Goto, Atsushi Nakamura, Takashi Nagaoka, Takayuki Sota

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the objective and quantitative hyperspectral parameters for distinguishing between age-related macular degeneration (AMD) and a normal macula.

Methods

Near-infrared hyperspectral images were taken of 71 eyes of 62 AMD patients with exudative AMD and 21 eyes of 12 control subjects without AMD. The spatial information included a 480 × 321-pixel image in a 50° field located at the ocular fundus and a 720–950-nm-per-pixel reflectance spectrum. Macular vectors were determined as the average spectrum for each macula, and reference vectors were used as average macular vectors for healthy volunteers. Variations in vector length and angle were calculated based on comparison with the reference vector. The AMD differentiation index was a parameter that minimized the plot overlap between AMD patients and controls.

Results

Statistically significant differences between the AMD patients and controls were noted. Receiver-operating characteristic curve analysis revealed an area under the curve of 0.888. The appropriate threshold values were attained for the proposed discrimination index, including 68 % sensitivity, 95 % specificity and 74 % accuracy.

Conclusions

This study presents a simplified diagnostic index for the determination of age-related macular degeneration based on near-infrared spectra.
Literatur
1.
Zurück zum Zitat Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol. 2001;85:1153–7.PubMedCrossRef Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol. 2001;85:1153–7.PubMedCrossRef
2.
Zurück zum Zitat Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology. 2002;109:1767–79.PubMedCrossRef Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology. 2002;109:1767–79.PubMedCrossRef
3.
Zurück zum Zitat Leske MC, Wu SY, Hennis A, Nemesure B, Yang L, Hyman L, et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology. 2006;113:29–35.PubMedCrossRef Leske MC, Wu SY, Hennis A, Nemesure B, Yang L, Hyman L, et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology. 2006;113:29–35.PubMedCrossRef
4.
Zurück zum Zitat Wang JJ, Rochtchina E, Lee AJ, Chia EM, Smith W, Cumming RG, et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology. 2007;114:92–8.PubMedCrossRef Wang JJ, Rochtchina E, Lee AJ, Chia EM, Smith W, Cumming RG, et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology. 2007;114:92–8.PubMedCrossRef
5.
Zurück zum Zitat Suzuki M, Gomi F, Sawa M, Tsujikawa M, Sakaguchi H. Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients. Jpn J Ophthalmol. 2010;54:124–8.PubMedCrossRef Suzuki M, Gomi F, Sawa M, Tsujikawa M, Sakaguchi H. Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients. Jpn J Ophthalmol. 2010;54:124–8.PubMedCrossRef
6.
Zurück zum Zitat Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999;117:1329–45. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999;117:1329–45.
7.
Zurück zum Zitat Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report no. 1. Ophthalmology. 2001;108:841–52. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report no. 1. Ophthalmology. 2001;108:841–52.
8.
Zurück zum Zitat Japanese age-related macular degeneration trial. 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2003;136:1049–61.CrossRef Japanese age-related macular degeneration trial. 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2003;136:1049–61.CrossRef
9.
Zurück zum Zitat Pieramici DJ, Bressler SB, Koester JM, Bressler NM. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP report no. 4. Arch Ophthalmol. 2006;124:660–4.PubMedCrossRef Pieramici DJ, Bressler SB, Koester JM, Bressler NM. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP report no. 4. Arch Ophthalmol. 2006;124:660–4.PubMedCrossRef
10.
Zurück zum Zitat Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.PubMedCrossRef Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.PubMedCrossRef
11.
Zurück zum Zitat Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol. 2006;124:1532–42.PubMedCrossRef Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol. 2006;124:1532–42.PubMedCrossRef
12.
Zurück zum Zitat Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.PubMedCrossRef Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.PubMedCrossRef
13.
Zurück zum Zitat Vo-Dinh T, Stokes DL, Wabuyele MB, Martin ME, Song JM, Jagannathan R, et al. A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest. IEEE Eng Med Biol Mag. 2004;23:40–9.PubMedCrossRef Vo-Dinh T, Stokes DL, Wabuyele MB, Martin ME, Song JM, Jagannathan R, et al. A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest. IEEE Eng Med Biol Mag. 2004;23:40–9.PubMedCrossRef
14.
Zurück zum Zitat Nagaoka T, Nakamura A, Okutani H, Kiyohara Y, Sota T. A possible melanoma discrimination index based on hyperspectral data: a pilot study. Skin Res Technol. 2012:301–10. Nagaoka T, Nakamura A, Okutani H, Kiyohara Y, Sota T. A possible melanoma discrimination index based on hyperspectral data: a pilot study. Skin Res Technol. 2012:301–10.
15.
Zurück zum Zitat Khoobehi B, Beach JM, Kawano H. Hyperspectral imaging for measurement of oxygen saturation in the optic nerve head. Invest Ophthalmol Vis Sci. 2004;45:1464–72.PubMedCrossRef Khoobehi B, Beach JM, Kawano H. Hyperspectral imaging for measurement of oxygen saturation in the optic nerve head. Invest Ophthalmol Vis Sci. 2004;45:1464–72.PubMedCrossRef
16.
Zurück zum Zitat Bernert G, von Siebenthal K, Kohlhauser C, Casaer P. Near infrared spectroscopy: methodological principles and clinical application in preterm infants. Wien Klin Wochenschr. 1995;107:569–73.PubMed Bernert G, von Siebenthal K, Kohlhauser C, Casaer P. Near infrared spectroscopy: methodological principles and clinical application in preterm infants. Wien Klin Wochenschr. 1995;107:569–73.PubMed
17.
Zurück zum Zitat Wyatt JS, Cope M, Delpy DT, Wray S, Reynolds EO. Quantification of cerebral oxygenation and haemodynamics in sick newborn infants by near infrared spectrophotometry. Lancet. 1986;2:1063–6.PubMedCrossRef Wyatt JS, Cope M, Delpy DT, Wray S, Reynolds EO. Quantification of cerebral oxygenation and haemodynamics in sick newborn infants by near infrared spectrophotometry. Lancet. 1986;2:1063–6.PubMedCrossRef
18.
Zurück zum Zitat Schweitzer D, Hammer M, Scibor M. Imaging spectrometry in ophthalmology–principle and applications in microcirculation and in investigation of pigments. Ophthal Res. 1996;28(Suppl 2):37–44.CrossRef Schweitzer D, Hammer M, Scibor M. Imaging spectrometry in ophthalmology–principle and applications in microcirculation and in investigation of pigments. Ophthal Res. 1996;28(Suppl 2):37–44.CrossRef
19.
Zurück zum Zitat Takahashi K, Ishibashi T, Ogur Y, Yuzawa M. Classification and diagnostic criteria of age-related macular degeneration. Nihon Ganka Gakkai Zasshi. 2008;112:1076–84. (in Japanese).PubMed Takahashi K, Ishibashi T, Ogur Y, Yuzawa M. Classification and diagnostic criteria of age-related macular degeneration. Nihon Ganka Gakkai Zasshi. 2008;112:1076–84. (in Japanese).PubMed
20.
Zurück zum Zitat Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763–70.PubMedCrossRef Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763–70.PubMedCrossRef
21.
Zurück zum Zitat Van Norren D, Tiemeijer LF. Spectral reflectance of the human eye. Vision Res. 1986;26:313–20.PubMedCrossRef Van Norren D, Tiemeijer LF. Spectral reflectance of the human eye. Vision Res. 1986;26:313–20.PubMedCrossRef
22.
Zurück zum Zitat Delori FC, Pflibsen KP. Spectral reflectance of the human ocular fundus. Appl Opt. 1989;28:1061–77.PubMedCrossRef Delori FC, Pflibsen KP. Spectral reflectance of the human ocular fundus. Appl Opt. 1989;28:1061–77.PubMedCrossRef
23.
Zurück zum Zitat Elsner AE, Burns SA, Weiter JJ, Delori FC. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res. 1996;36:191–205.PubMedCrossRef Elsner AE, Burns SA, Weiter JJ, Delori FC. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res. 1996;36:191–205.PubMedCrossRef
24.
Zurück zum Zitat Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.PubMed Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.PubMed
25.
Zurück zum Zitat Sarna T, Burke JM, Korytowski W, Rozanowska M, Skumatz CM, Zareba A, et al. Loss of melanin from human RPE with aging: possible role of melanin photooxidation. Exp Eye Res. 2003;76:89–98.PubMedCrossRef Sarna T, Burke JM, Korytowski W, Rozanowska M, Skumatz CM, Zareba A, et al. Loss of melanin from human RPE with aging: possible role of melanin photooxidation. Exp Eye Res. 2003;76:89–98.PubMedCrossRef
26.
Zurück zum Zitat Xu W, Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Martin ER, et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol. 2010;150:40–7 e42. Xu W, Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Martin ER, et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol. 2010;150:40–7 e42.
27.
Zurück zum Zitat Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:358–63.PubMedCrossRef Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:358–63.PubMedCrossRef
28.
Zurück zum Zitat Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116:150–4.PubMed Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116:150–4.PubMed
Metadaten
Titel
Novel automated screening of age-related macular degeneration
verfasst von
Yasuyuki Yamauchi
Hiroyuki Kemma
Hiroshi Goto
Atsushi Nakamura
Takashi Nagaoka
Takayuki Sota
Publikationsdatum
01.11.2012
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 6/2012
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-012-0184-x

Weitere Artikel der Ausgabe 6/2012

Japanese Journal of Ophthalmology 6/2012 Zur Ausgabe

Scientific Reviewers

Scientific Reviewers

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.